Clinical Study
Mortality in Levodopa-Treated Parkinson's Disease
Table 4
Mortality in PD patients stratified by age at death and disease duration.
| Age at death | Percentage of total dead | Observed deaths | Expected deaths | Mortality ratio | Number of PD deaths |
| 41–45 | 0.5 | 1 | 0.0189 | 52.91 | 0 | 46–50 | 0.5 | 1 | 0.0263 | 38.02 | 0 | 51–55 | 0.9 | 2 | 0.0778 | 25.71 | 1 | 56–60 | 1.9 | 4 | 0.6277 | 6.37 | 3 | 61–65 | 5.7 | 12 | 1.5998 | 7.50 | 5 | 66–70 | 13.3 | 28 | 6.3265 | 4.43 | 11 | 71–75 | 19.9 | 42 | 11.9488 | 3.52 | 24 | 76–80 | 33.2 | 70 | 26.5476 | 2.64 | 39 | 81–85 | 16.1 | 34 | 18.5483 | 1.83 | 20 | 86–90 | 7.6 | 16 | 12.5786 | 1.27 | 7 | 91–95 | 0.5 | 1 | 1.0000 | 1.00 | 1 |
| Disease duration | Percentage of total dead | Observed deaths | Expected deaths | Mortality ratio | Number of PD deaths |
| 1–5 | 17.5 | 37 | 7.0770 | 5.23 | 16 | 6–10 | 29.4 | 62 | 20.7956 | 2.98 | 28 | 11–15 | 25.6 | 54 | 23.7313 | 2.28 | 34 | 16–20 | 16.6 | 35 | 15.9910 | 2.19 | 22 | 21–25 | 8.1 | 17 | 7.7683 | 2.19 | 8 | 26+ | 2.8 | 6 | 3.9371 | 1.52 | 3 |
|
|